1-4 of 4
hla-a2 antigen
Close
Sort by
Journal Articles

Human CD8 + Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice

Séverine Bézie, Béatrice Charreau, Nadège Vimond, Juliette Lasselin, Nathalie Gérard, Véronique Nerrière-Daguin, Frédérique Bellier-Waast, Franck Duteille, Ignacio Anegon, Carole Guillonneau
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3522–3538.
https://doi.org/10.1182/bloodadvances.2019000411
Published: 2019
Includes: Supplemental data
Journal Articles

Identification of a tumor-specific allo-HLA–restricted γδTCR

G. J. J. Kierkels, W. Scheper, A. D. Meringa, I. Johanna, D. X. Beringer, A. Janssen, M. Schiffler, T. Aarts-Riemens, L. Kramer, T. Straetemans, S. Heijhuurs, J. H. W. Leusen, E. San José, K. Fuchs, M. Griffioen, J. H. Falkenburg, L. Bongiovanni, A. de Bruin, D. Vargas-Diaz, M. Altelaar, A. J. R. Heck, L. D. Shultz, F. Ishikawa, M. I. Nishimura, Z. Sebestyén, J. Kuball
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2870–2882.
https://doi.org/10.1182/bloodadvances.2019032409
Published: 2019
Includes: Supplemental data
Journal Articles

Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens

Jefferson L. Lansford, Udara Dharmasiri, Shengjie Chai, Sally A. Hunsucker, Dante S. Bortone, James E. Keating, Ian M. Schlup, Gary L. Glish, Edward J. Collins, Gheath Alatrash, Jeffrey J. Molldrem, Paul M. Armistead, Benjamin G. Vincent
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2052–2062.
https://doi.org/10.1182/bloodadvances.2018022475
Published: 2018
Includes: Supplemental data
Journal Articles

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia

Clinical Trials & Observations
Peter G. Maslak, Tao Dao, Yvette Bernal, Suzanne M. Chanel, Rong Zhang, Mark Frattini, Todd Rosenblat, Joseph G. Jurcic, Renier J. Brentjens, Maria E. Arcila, Raajit Rampal, Jae H. Park, Dan Douer, Laura Katz, Nicholas Sarlis, Martin S. Tallman, David A. Scheinberg
Journal: Blood Advances
Blood Adv (2018) 2 (3): 224–234.
https://doi.org/10.1182/bloodadvances.2017014175
Published: 2018
Includes: Supplemental data